Literature DB >> 16487524

Issues in the planning and conduct of randomised trials.

Mohit Bhandari1, Hans C Pape, Peter V Giannoudis.   

Abstract

Randomised trials top the hierarchy of evidence. To provide the best evidence to guide surgical practice, randomised trials must answer clinically important questions, have important and objective outcome measurement and be sufficiently powered to detect important differences between interventions. Investigators who adhere to these principles are more likely to succeed during the conduct of their trials.

Mesh:

Year:  2006        PMID: 16487524     DOI: 10.1016/j.injury.2006.02.002

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  5 in total

1.  Are large fracture trials really possible? What we have learned from the randomized controlled damage control study?

Authors:  Eva Steinhausen; Bertil Bouillon; Dieter Rixen
Journal:  Eur J Trauma Emerg Surg       Date:  2017-12-28       Impact factor: 3.693

2.  Impact of the method of initial stabilization for femoral shaft fractures in patients with multiple injuries at risk for complications (borderline patients).

Authors:  Hans-Christoph Pape; Dieter Rixen; John Morley; Elisabeth Ellingsen Husebye; Michael Mueller; Clemens Dumont; Andreas Gruner; Hans Joerg Oestern; Michael Bayeff-Filoff; Christina Garving; Dustin Pardini; Martijn van Griensven; Christian Krettek; Peter Giannoudis
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

3.  (Sample) size matters! An examination of sample size from the SPRINT trial study to prospectively evaluate reamed intramedullary nails in patients with tibial fractures.

Authors:  Mohit Bhandari; Paul Tornetta; Shelly-Ann Rampersad; Sheila Sprague; Diane Heels-Ansdell; David W Sanders; Emil H Schemitsch; Marc Swiontkowski; Stephen Walter
Journal:  J Orthop Trauma       Date:  2013-04       Impact factor: 2.512

4.  Publication trend of COVID-19 and non-COVID-19 articles in the Indian Journal of Ophthalmology during the pandemic.

Authors:  Bharat Gurnani; Kirandeep Kaur
Journal:  Indian J Ophthalmol       Date:  2021-05       Impact factor: 1.848

5.  Research and Publishing in the COVID-19 Pandemic.

Authors:  Ian D Civil; Peter V Giannoudis
Journal:  Injury       Date:  2020-05       Impact factor: 2.586

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.